Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Approvals Action
Trio of new drugs on ARTG

Posted 23 November 2020 

Three new drugs appeared on the ARTG for the first time last week while the TGA approved new doses of medicines yet to face generic competitors.

The first timers were Roche's neuromyelitis optica spectrum disorder treatment Enspryng, Gedeon Richter's schizophrenia drug Reagila and Clinuvel Pharmaceuticals home-grown light-sensitivity drug Scenesse. Scenesse was green-lighted by the regulatory body under priority review last month.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Picking the path out of Covid
Now is not the time for leaders to play it safe
Special Report
Aust Covid Vaccine Tracker
UPDATE: Gilead hits back at WHO over remdesivir
Approvals Action
Trio of new drugs on ARTG
Roche, Seqirus, Clinuvel enlarge local portfolios